0001209191-19-016770.txt : 20190305
0001209191-19-016770.hdr.sgml : 20190305
20190305173547
ACCESSION NUMBER: 0001209191-19-016770
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190301
FILED AS OF DATE: 20190305
DATE AS OF CHANGE: 20190305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Andrews William T.
CENTRAL INDEX KEY: 0001638459
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33004
FILM NUMBER: 19659847
MAIL ADDRESS:
STREET 1: ONE MAIN STREET, SUITE 800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acer Therapeutics Inc.
CENTRAL INDEX KEY: 0001069308
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320426967
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.)
STREET 2: SUITE 351
CITY: NEWTON
STATE: MA
ZIP: 02458
BUSINESS PHONE: (844) 902-6100
MAIL ADDRESS:
STREET 1: ONE GATEWAY CENTER (300 WASHINGTON ST.)
STREET 2: SUITE 351
CITY: NEWTON
STATE: MA
ZIP: 02458
FORMER COMPANY:
FORMER CONFORMED NAME: Opexa Therapeutics, Inc.
DATE OF NAME CHANGE: 20060616
FORMER COMPANY:
FORMER CONFORMED NAME: PharmaFrontiers Corp.
DATE OF NAME CHANGE: 20051011
FORMER COMPANY:
FORMER CONFORMED NAME: PHARMAFRONTIERS CORP
DATE OF NAME CHANGE: 20040816
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-01
0
0001069308
Acer Therapeutics Inc.
ACER
0001638459
Andrews William T.
C/O ACER THERAPEUTICS INC.
ONE GATEWAY CTR. STE 351
NEWTON
MA
02458
0
1
0
0
Chief Medical Officer
Common Stock
2019-03-01
4
A
0
9000
0.00
A
9000
D
Shares issuable upon settlement of a restricted stock unit award that vests in full on March 1, 2020.
/s/ Harry Palmin, Attorney-in-fact
2019-03-05